Development of a prognostic signature for esophageal cancer based on nine immune related genes

Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia

12 p | 11 | 4

An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma

17 p | 14 | 3

Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme

14 p | 11 | 3

Development of prognostic signatures for intermediate-risk papillary thyroid cancer

12 p | 17 | 2

A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer

18 p | 2 | 2

Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma

16 p | 2 | 1

Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis

16 p | 15 | 1

Circulating miR-200c and miR-141 and outcomes in patients with breast cancer

15 p | 11 | 1

Development of a miRNA-seq based prognostic signature in lung adenocarcinoma

10 p | 6 | 0